INTRAVENOUS SULPROSTONE AND UTERINE SCARRING BASED UPON 22 CASES OF THERAPEUTIC-ABORTION DURING 2ND AND 3RD TRIMESTERS OF PREGNANCY

A preliminary study in 22 patients with uterine scarring was undertake n using sulprostone by intravenous infusion when therapeutic abortion was deemed necessary during the 2nd and 3rd trimesters of pregnancy. T he dosage used was 500 mug by slow infusion lasting 10 h. There were n o cases of ruptured uterus. Adverse reactions were absent. Results wer e satisfactory. Mean induction-expulsion duration: 11 h. Expulsion rat e in 24 h: 63%. With strict monitoring and in a specialized center, th is technique may be suggested when a late therapeutic abortion with a scarred uterus is indicated.